Emerging mechanisms of enzalutamide resistance in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging mechanisms of enzalutamide resistance in prostate cancer

Published:2014-09-16 Issue:12 Volume:11 Page:712-716
ISSN:1759-4812
Container-title:Nature Reviews Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Claessens Frank,Helsen Christine,Prekovic Stefan,Van den Broeck Thomas,Spans Lien,Van Poppel Hendrik,Joniau Steven

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/nrurol.2014.243.pdf

Reference42 articles.

1. van Soest, R. J. et al. Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer. Eur. J. Cancer 49, 3821–3830 (2013).

2. Rathkopf, D. E. et al. Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302). Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2014.02.056 .

3. Scher, H. I. et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N. Engl. J. Med. 367, 1187–1197 (2012).

4. Zong, Y. & Goldstein, A. S. Adaptation or selection—mechanisms of castration-resistant prostate cancer. Nat. Rev. Urol. 10, 90–98 (2013).

5. Claessens, F. et al. Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl. Recept. Signal. 6, e008 (2008).

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells;Cancers;2024-08-24

2. Nanomedicines in diagnosis and treatment of prostate cancers: an updated review;Frontiers in Bioengineering and Biotechnology;2024-08-21

3. Synergistic combination therapy with ONC201 or ONC206, Enzalutamide and Darolutamide in preclinical studies of castration-resistant prostate cancer;2024-08-01

4. Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium;Journal of Experimental & Clinical Cancer Research;2024-07-17

5. Mitochondrial Elongation and ROS-Mediated Apoptosis in Prostate Cancer Cells under Therapy with Apalutamide and Complex I Inhibitor;International Journal of Molecular Sciences;2024-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3